טיגציל

Šalis: Izraelis

kalba: hebrajų

Šaltinis: Ministry of Health

Veiklioji medžiaga:

TIGECYCLINE

Prieinama:

PFIZER PHARMACEUTICALS ISRAEL LTD

ATC kodas:

J01AA12

Vaisto forma:

אבקה מיובשת בהקפאה לאינפוזיה

Sudėtis:

TIGECYCLINE 50 MG/DOSE

Vartojimo būdas:

תוך-ורידי

Recepto tipas:

מרשם נדרש

Pagaminta:

PFIZER PHARMACEUTICALS LLC, PFIZER PHARMACEUTICALS LLC-PIPERACILLIN, PUERTO RICO

Farmakoterapinė grupė:

TIGECYCLINE

Gydymo sritis:

TIGECYCLINE

Terapinės indikacijos:

TYGACIL is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below for patients 18 years of age and older:Complicated Skin and Skin Structure Infections:Complicated skin and skin structure infections caused by Escherichia coli, Enterococcus faecalis (vancomycin-susceptible isolates ), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus agalactiae, Streptococcus anginosus grp. (includes S. anginosus, S. intermedius, and S. constellatus), Streptococcus pyogenes, Enterobacter cloacae, Klebsiella pneumoniae, and Bacteroides fragilis .Complicated Intra-abdominal Infections:Complicated intra-abdominal infections caused by Citrobacter freundii, Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Enterococcus faecalis (vancomycin-susceptible isolates), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus anginosus grp. (includes S. anginosu

Leidimo data:

2012-02-28